William Rosenfeld
Neurology · Chesterfield, MONPI 1851413587
Payments from drug & device makers
Across 471 payments — averaging $4928.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SK Life Science, Inc.$2.1M
- UCB, Inc.$156K
- GW Research Limited$21K
- UCB Biosciences Inc.$7K
- Greenwich Biosciences, Inc.$6K
- Takeda Pharmaceuticals U.S.A., Inc.$3K
- plus $196 from 4 others
Across 10 payments — averaging $11,470 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- SK Life Science, Inc.$115K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SK Life Science, Inc. | 446 | $2,127,442 |
| UCB, Inc. | 3 | $156,445 |
| GW Research Limited | 1 | $20,674 |
| UCB Biosciences Inc. | 1 | $7,477 |
| Greenwich Biosciences, Inc. | 10 | $6,417 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $2,826 |
| Jazz Pharmaceuticals Inc. | 1 | $84 |
| Neurelis, Inc. | 2 | $72 |
| Assertio Therapeutics, Inc. | 2 | $27 |
| UCB SA | 1 | $14 |
How this compares
$2,321,477 in reported general payments places this provider in the 95th percentile of 381 neurology providers in Missouri.
Other neurology in Chesterfield
- Barbara GreenChesterfield$608K
- Max BenzaquenChesterfield$296K
- Randall BatemanSaint Louis$92.3M
- David HoltzmanSaint Louis$25.2M
- Robert NaismithSaint Louis$13.8M
- Eric McDadeSaint Louis$9.6M
- Robert BucelliSaint Louis$8.5M
- Barbara SniderSaint Louis$7M
- Curtis SchreiberBolivar$6.4M
- Gregory WuSaint Louis$5.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.